186 related articles for article (PubMed ID: 2883055)
1. Greater efficacy of pulsatile insulin in type I diabetics critically depends on plasma glucagon levels.
Paolisso G; Sgambato S; Passariello N; Scheen A; D'Onofrio F; Lefèbvre PJ
Diabetes; 1987 May; 36(5):566-70. PubMed ID: 2883055
[TBL] [Abstract][Full Text] [Related]
2. Pulsatile hyperglucagonemia fails to increase hepatic glucose production in normal man.
Paolisso G; Scheen AJ; Luyckx AS; Lefebvre PJ
Am J Physiol; 1987 Jan; 252(1 Pt 1):E1-7. PubMed ID: 3544860
[TBL] [Abstract][Full Text] [Related]
3. Advantageous metabolic effects of pulsatile insulin delivery in noninsulin-dependent diabetic patients.
Paolisso G; Sgambato S; Gentile S; Memoli P; Giugliano D; Varricchio M; D'Onofrio F
J Clin Endocrinol Metab; 1988 Nov; 67(5):1005-10. PubMed ID: 3053747
[TBL] [Abstract][Full Text] [Related]
4. Effects of pulsatile delivery of insulin and glucagon in humans.
Paolisso G; Scheen AJ; Albert A; Lefebvre PJ
Am J Physiol; 1989 Nov; 257(5 Pt 1):E686-96. PubMed ID: 2688437
[TBL] [Abstract][Full Text] [Related]
5. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans.
Saccà L; Sherwin R; Hendler R; Felig P
J Clin Invest; 1979 May; 63(5):849-57. PubMed ID: 447832
[TBL] [Abstract][Full Text] [Related]
6. Pulsatile rather than continuous glucagon infusion leads to greater metabolic derangements in insulin-dependent diabetic subjects.
Paolisso G; Sgambato S; Giunta R; Varricchio M; D'Onofrio F
Diabete Metab; 1990; 16(1):42-7. PubMed ID: 2332096
[TBL] [Abstract][Full Text] [Related]
7. Pulsatile insulin delivery is more efficient than continuous infusion in modulating islet cell function in normal subjects and patients with type 1 diabetes.
Paolisso G; Sgambato S; Torella R; Varricchio M; Scheen A; D'Onofrio F; Lefèbvre PJ
J Clin Endocrinol Metab; 1988 Jun; 66(6):1220-6. PubMed ID: 3286673
[TBL] [Abstract][Full Text] [Related]
8. Insulin oscillations per se do not affect glucose turnover parameters in normal man.
Paolisso G; Scheen AJ; Verdin EM; Luyckx AS; Lefebvre PJ
J Clin Endocrinol Metab; 1986 Aug; 63(2):520-5. PubMed ID: 3522623
[TBL] [Abstract][Full Text] [Related]
9. Pulsatile insulin delivery has greater metabolic effects than continuous hormone administration in man: importance of pulse frequency.
Paolisso G; Scheen AJ; Giugliano D; Sgambato S; Albert A; Varricchio M; D'Onofrio F; Lefèbvre PJ
J Clin Endocrinol Metab; 1991 Mar; 72(3):607-15. PubMed ID: 1997515
[TBL] [Abstract][Full Text] [Related]
10. Pulsatile glucagon has greater hyperglycaemic, lipolytic and ketogenic effects than continuous hormone delivery in man: effect of age.
Paolisso G; Buonocore S; Gentile S; Sgambato S; Varricchio M; Scheen A; D'Onofrio F; Lefèbvre PJ
Diabetologia; 1990 May; 33(5):272-7. PubMed ID: 2198186
[TBL] [Abstract][Full Text] [Related]
11. Islet hormonal regulation of glucose turnover during exercise in type 1 diabetes.
Shilo S; Sotsky M; Shamoon H
J Clin Endocrinol Metab; 1990 Jan; 70(1):162-72. PubMed ID: 1967178
[TBL] [Abstract][Full Text] [Related]
12. Contrasting metabolic effects of continuous and pulsatile growth hormone administration in young adults with type 1 (insulin-dependent) diabetes mellitus.
Pal BR; Phillips PE; Matthews DR; Dunger DB
Diabetologia; 1992 Jun; 35(6):542-9. PubMed ID: 1612227
[TBL] [Abstract][Full Text] [Related]
13. Effect of intermittent endogenous hyperglucagonemia on glucose homeostasis in normal and diabetic man.
Rizza R; Verdonk C; Miles J; Service FJ; Gerich J
J Clin Invest; 1979 Jun; 63(6):1119-23. PubMed ID: 447838
[TBL] [Abstract][Full Text] [Related]
14. Effect of insulin-glucose infusions on plasma glucagon levels in fasting diabetics and nondiabetics.
Raskin P; Fujita Y; Unger RH
J Clin Invest; 1975 Nov; 56(5):1132-8. PubMed ID: 1184740
[TBL] [Abstract][Full Text] [Related]
15. Basal insulin, glucagon, and growth hormone replacement.
Breckenridge SM; Raju B; Arbelaez AM; Patterson BW; Cooperberg BA; Cryer PE
Am J Physiol Endocrinol Metab; 2007 Nov; 293(5):E1303-10. PubMed ID: 17711984
[TBL] [Abstract][Full Text] [Related]
16. Insulin effects on glucose kinetics in non-insulin-dependent diabetic patients with secondary failure to hypoglycaemic agents: role of different modes and rates of delivery.
Paolisso G; Sgambato S; Varricchio M; Scheen AJ; D'Onofrio F; Lefèbvre P
Eur J Med; 1992 Sep; 1(5):261-7. PubMed ID: 1341607
[TBL] [Abstract][Full Text] [Related]
17. 24-hour studies of the effects of somatostatin on the levels of plasma growth hormone, glucagon, and glucose in normal subjects and juvenile diabetics.
Christensen SE; Hansen AP; Weeke J; Lundbaek K
Diabetes; 1978 Mar; 27(3):300-6. PubMed ID: 640235
[TBL] [Abstract][Full Text] [Related]
18. Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism. Studies involving administration of exogenous hormone during suppression of endogenous hormone secretion with somatostatin.
Gerich JE; Lorenzi M; Bier DM; Tsalikian E; Schneider V; Karam JH; Forsham PH
J Clin Invest; 1976 Apr; 57(4):875-84. PubMed ID: 820717
[TBL] [Abstract][Full Text] [Related]
19. Similar metabolic effects of pulsatile versus continuous human insulin delivery during euglycemic, hyperinsulinemic glucose clamp in normal man.
Verdin E; Castillo M; Luyckx AS; Lefebvre PJ
Diabetes; 1984 Dec; 33(12):1169-74. PubMed ID: 6389233
[TBL] [Abstract][Full Text] [Related]
20. Peripheral and hepatic resistance to insulin and hepatic resistance to glucagon in uraemic subjects. Studies at physiologic and supraphysiologic hormone levels.
Schmitz O
Acta Endocrinol (Copenh); 1988 May; 118(1):125-34. PubMed ID: 2898853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
